![]() SABA, short-acting beta agonist SAMA, short-acting muscarinic antagonist LAMA, long-acting muscarinic antagonist LABA, long-acting beta agonist ICS: inhaled corticosteroid. umeclidinium + vilanterol (Anoro DPI) are now subsidised. ![]() glycopyrronium + indacaterol (Ultibro DPI), olodaterol + tiotropium, (Spiolto MDI) and. *NICE suggests a baseline level of exacerbations to consider starting ICS to be 1 severe (requiring hospitalisation) or 2 moderate (requiring steroids or antibiotics) exacerbations per year. medicine and combination inhalers Olodaterol, a LABA, is a new medicine to New Zealand and is subsidised as a combination inhaler hree combination LAMA/LABAs inhalers, T.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |